Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

PROCLAIM: Germline Genetic Testing for Prostate Cancer Patients

ClinicalTrials.gov ID: NCT05447637

Public ClinicalTrials.gov record NCT05447637. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center Prospective Observational Study of Community Urology Practices Applying Germline Genetic Testing for Prostate Cancer Patients (PROCLAIM)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This registry is for men who have prostate cancer and have had multigene panel hereditary testing. The registry will gather data on genetic testing results and how that information may change physician treatment or follow up recommendations. It will also gather data on the patient's experience with genetic testing, through a post-test survey to be completed 60-90days after results have been received and discussed with their provider.

Study identification

NCT ID
NCT05447637
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Invitae Corporation
Industry
Enrollment
1,000 participants

Conditions and interventions

Interventions

Diagnostic Test

Eligibility (public fields only)

Age range
18 Years to 90 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 1, 2019 (Actual)
Primary completion
Jul 1, 2021 (Actual)
Completion
May 31, 2022 (Actual)
Last update posted
Jul 7, 2022

2019 – 2022

United States locations

U.S. sites
19
U.S. states
11
U.S. cities
16
Facility City State ZIP Site status
Genesis Healthcare Partners San Diego California 92123 —
Invitae San Francisco California 94103 —
Department of Bioengineering and Therapeutic Sciences, University of California San Francisco San Francisco California 94158 —
Volunteer Faculty, University of California San Francisco San Francisco California 94158 —
Colorado Urology Lakewood Colorado 80228 —
Advanced Urology Institute St. Petersburg Florida 33710 —
Florida Urology Partners Tampa Florida 33606 —
TGH Cancer Institute Tampa Florida 33606 —
North Georgia Urology Dalton Georgia 30720 —
Associated Urological Specialists Chicago Ridge Illinois 60415 —
University Urology Associates of New Jersey Hamilton New Jersey 08690 —
Perlmutter Cancer Center, NYU Langone Health, New York New York New York 10016 —
Associated Medical Professionals Syracuse New York 13210 —
MidLantic Urology Bala-Cynwyd Pennsylvania 19004 —
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 —
Urology Associates, P.C. Nashville Tennessee 37211 —
Urology Partners Arlington Texas 76017 —
Urology Austin Austin Texas 78759 —
Urosurgery Houston Houston Texas 77002 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05447637, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 7, 2022 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05447637 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →